420 related articles for article (PubMed ID: 17101475)
1. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases.
Zöller M; Gupta P; Marhaba R; Vitacolonna M; Freyschmidt-Paul P
J Leukoc Biol; 2007 Jul; 82(1):57-71. PubMed ID: 17442857
[TBL] [Abstract][Full Text] [Related]
4. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
Wasyłyszyn T; Kozłowski W; Zabielski SL
Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
J Autoimmun; 2004 Nov; 23(3):241-56. PubMed ID: 15501395
[TBL] [Abstract][Full Text] [Related]
6. Pronounced perifollicular lymphocytic infiltrates in alopecia areata are associated with poor treatment response to diphencyprone.
Freyschmidt-Paul P; Hamm H; Happle R; Hoffmann R
Eur J Dermatol; 1999 Mar; 9(2):111-4. PubMed ID: 10066958
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
8. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P
Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876
[TBL] [Abstract][Full Text] [Related]
9. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
Sato-Kawamura M; Aiba S; Tagami H
Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
[TBL] [Abstract][Full Text] [Related]
11. A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata.
Gupta P; Freyschmidt-Paul P; Vitacolonna M; Kiessling S; Hummel S; Hildebrand D; Marhaba R; Zöller M
J Invest Dermatol; 2006 Jul; 126(7):1559-73. PubMed ID: 16675965
[TBL] [Abstract][Full Text] [Related]
12. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
[TBL] [Abstract][Full Text] [Related]
13. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
[TBL] [Abstract][Full Text] [Related]
14. In vivo CD44-CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance.
Marhaba R; Freyschmidt-Paul P; Zöller M
Eur J Immunol; 2006 Nov; 36(11):3017-32. PubMed ID: 17039568
[TBL] [Abstract][Full Text] [Related]
15. Effects of diphencyprone on expression of Bcl-2 protein in patients with alopecia areata.
Pazoki-Toroudi H; Ajami M; Babakoohi S; Khaki L; Habibey R; Akhiani M; Seirafi H; Firooz A
Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):422-5. PubMed ID: 20095801
[TBL] [Abstract][Full Text] [Related]
16. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
[TBL] [Abstract][Full Text] [Related]
17. Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells.
Singh V; Mueller U; Freyschmidt-Paul P; Zöller M
Eur J Immunol; 2011 Oct; 41(10):2871-82. PubMed ID: 21728175
[TBL] [Abstract][Full Text] [Related]
18. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
[TBL] [Abstract][Full Text] [Related]
19. The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells.
Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
Exp Dermatol; 2004 Jul; 13(7):435-44. PubMed ID: 15217364
[TBL] [Abstract][Full Text] [Related]
20. Type 1 interferon signature in the scalp lesions of alopecia areata.
Ghoreishi M; Martinka M; Dutz JP
Br J Dermatol; 2010 Jul; 163(1):57-62. PubMed ID: 20346028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
